WO2003033534A3 - Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof - Google Patents
Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof Download PDFInfo
- Publication number
- WO2003033534A3 WO2003033534A3 PCT/IB2002/004635 IB0204635W WO03033534A3 WO 2003033534 A3 WO2003033534 A3 WO 2003033534A3 IB 0204635 W IB0204635 W IB 0204635W WO 03033534 A3 WO03033534 A3 WO 03033534A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- metabolic
- pgzipd
- pgzipa
- ngzipd
- ngzipa
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL16123402A IL161234A0 (en) | 2001-10-12 | 2002-10-03 | Ngzipa, ngzipd, pgzipa and pgzipd polynucleotides and polypeptides and uses thereof |
AU2002339686A AU2002339686B2 (en) | 2001-10-12 | 2002-10-03 | NGZIPA, NGZIPD, PGZIPA, and PGZIPD polynucleotides and polypeptides and uses thereof |
EP02777735A EP1436326A2 (en) | 2001-10-12 | 2002-10-03 | Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof |
JP2003536272A JP2005514010A (en) | 2001-10-12 | 2002-10-03 | NGZIPA, NGZIPD, PGZIPA and PGZIPD polynucleotides and polypeptides, and uses thereof |
US10/492,179 US20050065079A1 (en) | 2001-10-12 | 2002-10-03 | Ngzipa,ngzipd,pgzipa and pgzipd polynucleotides and polypeptides and uses thereof |
CA002462588A CA2462588A1 (en) | 2001-10-12 | 2002-10-03 | Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32907401P | 2001-10-12 | 2001-10-12 | |
US60/329,074 | 2001-10-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003033534A2 WO2003033534A2 (en) | 2003-04-24 |
WO2003033534A3 true WO2003033534A3 (en) | 2003-10-02 |
Family
ID=23283741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2002/004635 WO2003033534A2 (en) | 2001-10-12 | 2002-10-03 | Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof |
Country Status (7)
Country | Link |
---|---|
US (1) | US20050065079A1 (en) |
EP (1) | EP1436326A2 (en) |
JP (1) | JP2005514010A (en) |
AU (1) | AU2002339686B2 (en) |
CA (1) | CA2462588A1 (en) |
IL (1) | IL161234A0 (en) |
WO (1) | WO2003033534A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7223727B2 (en) * | 1998-04-09 | 2007-05-29 | Serono Genetics Institute S.A. | GSSP4 polynucleotides and polypeptides and uses thereof |
ATE464378T1 (en) * | 2000-05-31 | 2010-04-15 | Serono Genetics Inst Sa | USING ACRP30'S GLOBULAR HEAD TO Amplify MUSCLE MASS AND DIFFERENTIATION INCREASE |
US7402393B2 (en) * | 2001-10-05 | 2008-07-22 | Serono Genetics Institute S.A. | Methods of screening for antagonists of APM1/GZIP |
US7459433B2 (en) | 2002-05-31 | 2008-12-02 | Serono Genetics Institute, S.A. | Homotrimeric extended OBG3 globular head and uses thereof |
ES2551877T3 (en) * | 2009-10-19 | 2015-11-24 | Rostaquo S.P.A. | Rostafuroxin for the pharmacokinetic treatment of cardiovascular conditions |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999062939A2 (en) * | 1998-05-29 | 1999-12-09 | Michael John Tisdale | Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6812339B1 (en) * | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
-
2002
- 2002-10-03 IL IL16123402A patent/IL161234A0/en unknown
- 2002-10-03 JP JP2003536272A patent/JP2005514010A/en active Pending
- 2002-10-03 AU AU2002339686A patent/AU2002339686B2/en not_active Ceased
- 2002-10-03 US US10/492,179 patent/US20050065079A1/en not_active Abandoned
- 2002-10-03 EP EP02777735A patent/EP1436326A2/en not_active Withdrawn
- 2002-10-03 CA CA002462588A patent/CA2462588A1/en not_active Abandoned
- 2002-10-03 WO PCT/IB2002/004635 patent/WO2003033534A2/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999062939A2 (en) * | 1998-05-29 | 1999-12-09 | Michael John Tisdale | Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
Non-Patent Citations (4)
Title |
---|
DATABASE EMBL [online] 17 July 2001 (2001-07-17), XP002230652, retrieved from EBI Database accession no. BC005908 * |
DATABASE SWISSPROT [online] 1 May 1992 (1992-05-01), XP002230651, retrieved from EBI Database accession no. P25311 * |
KENNEDY MALCOLM W ET AL: "Hydrophobic ligand binding by Zn-alpha2-glycoprotein, a soluble fat-depleting factor related to major histocompatibility complex proteins.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 276, no. 37, 14 September 2001 (2001-09-14), pages 35008 - 35013, XP002230650, ISSN: 0021-9258 * |
SANCHES LM ET AL.: "Crystal structure of human ZAG, a fat-depleting factor related to MCH molecules.", SCIENCE, vol. 283, - 19 March 1999 (1999-03-19), pages 1914-1919, XP002230649 * |
Also Published As
Publication number | Publication date |
---|---|
US20050065079A1 (en) | 2005-03-24 |
WO2003033534A2 (en) | 2003-04-24 |
EP1436326A2 (en) | 2004-07-14 |
CA2462588A1 (en) | 2003-04-24 |
IL161234A0 (en) | 2004-09-27 |
AU2002339686B2 (en) | 2007-12-20 |
JP2005514010A (en) | 2005-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL150554A0 (en) | Obg3 globular head and uses therof for decreasing body mass | |
WO2003057666A3 (en) | Inhibitors of dipeptidyl peptidase iv | |
HRP20041180A2 (en) | 11-beta-hidroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia | |
PL366619A1 (en) | Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders | |
AU2002258428A1 (en) | Methods for the treatment of metabolic disorders, including obesity and diabetes | |
MXPA04003796A (en) | Substituted thioacetamides. | |
AU2003259706A1 (en) | Therapeutic process for the treatment of obesity and associated metabolic disorders | |
MXPA03008634A (en) | Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases. | |
WO2003039453A3 (en) | Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use | |
EP1379236A4 (en) | Treatment of tics, tremors and related disorders | |
WO2003033534A3 (en) | Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof | |
WO2003050281A3 (en) | Fragments of the human zn-alpha2-glycolprotein and their use in methods of treatment of obesity | |
WO2002066505A3 (en) | Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof | |
WO2002060466A3 (en) | Gssp3 polynucleotides and polypeptides and uses thereof | |
WO2003051911A3 (en) | Gmg-5 polynucleotides and polypeptides and uses thereof | |
WO2003082915A3 (en) | Xcrf polynucleotides and polypeptides and uses thereof | |
WO2001070737A3 (en) | Therapeutic heterocyclic compounds for the treatment of asthma and allergy and use thereof | |
AU2002365936A1 (en) | Compositions and methods to treat gastrointestinal disorders | |
WO2002055694A3 (en) | Discriminative nucleic acid analysis using clone sequence signatures | |
WO2002069689A3 (en) | Gssp4 polynucleotides and polypeptides and uses thereof | |
WO2002058724A3 (en) | Use of lp82 to treat body weight disorders | |
WO2003095485A3 (en) | Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders | |
AU2003283938A1 (en) | Use of certain compounds in treatment of obesity | |
WO2003013578A8 (en) | Omoxin agonists and antagonists for use in the treatment of metabolic disorders | |
WO2001028582A3 (en) | Therapeutic applications of flint polypeptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2462588 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 161234 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002777735 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003536272 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002339686 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2002777735 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10492179 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2002339686 Country of ref document: AU Date of ref document: 20021003 Kind code of ref document: B |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002777735 Country of ref document: EP |